000285439 001__ 285439
000285439 005__ 20240229155110.0
000285439 0247_ $$2doi$$a10.1186/s12967-023-04611-8
000285439 0247_ $$2pmid$$apmid:37978524
000285439 0247_ $$2pmc$$apmc:PMC10655258
000285439 037__ $$aDKFZ-2023-02373
000285439 041__ $$aEnglish
000285439 082__ $$a610
000285439 1001_ $$aKong, Yue$$b0
000285439 245__ $$aPalmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis.
000285439 260__ $$aLondon$$bBioMed Central$$c2023
000285439 3367_ $$2DRIVER$$aarticle
000285439 3367_ $$2DataCite$$aOutput Types/Journal article
000285439 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1700481633_7064
000285439 3367_ $$2BibTeX$$aARTICLE
000285439 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285439 3367_ $$00$$2EndNote$$aJournal Article
000285439 500__ $$a#EA:C070#
000285439 520__ $$aProtein palmitoylation, which is catalyzed by palmitoyl-transferase and de-palmitoyl-transferase, plays a crucial role in various biological processes. However, the landscape and dynamics of protein palmitoylation in human cancers are not well understood.We utilized 23 palmitoyl-acyltransferases and seven de-palmitoyl-acyltransferases as palmitoylation-related genes for protein palmitoylation analysis. Multiple publicly available datasets were employed to conduct pan-cancer analysis, examining the transcriptome, genomic alterations, clinical outcomes, and correlation with c-Myc (Myc) for palmitoylation-related genes. Real-time quantitative PCR and immunoblotting were performed to assess the expression of palmitoylation-related genes and global protein palmitoylation levels in cancer cells treated with Myc depletion or small molecule inhibitors. Protein docking and drug sensitivity analyses were employed to predict small molecules that target palmitoylation-related genes.We identified associations between palmitoylation and cancer subtype, stage, and patient survival. We discovered that abnormal DNA methylation and oncogenic Myc-driven transcriptional regulation synergistically contribute to the dysregulation of palmitoylation-related genes. This dysregulation of palmitoylation was closely correlated with immune infiltration in the tumor microenvironment and the response to immunotherapy. Importantly, dysregulated palmitoylation was found to modulate canonical cancer-related pathways, thus influencing tumorigenesis. To support our findings, we performed a proof-of-concept experiment showing that depletion of Myc led to reduced expression of most palmitoylation-related genes, resulting in decreased global protein palmitoylation levels. Through mass spectrometry and enrichment analyses, we also identified palmitoyl-acyltransferases ZDHHC7 and ZDHHC23 as significant contributors to mTOR signaling, DNA repair, and immune pathways, highlighting their potential roles in tumorigenesis. Additionally, our study explored the potential of three small molecular (BI-2531, etoposide, and piperlongumine) to modulate palmitoylation by targeting the expression or activity of palmitoylation-related genes or enzymes.Overall, our findings underscore the critical role of dysregulated palmitoylation in tumorigenesis and the response to immunotherapy, mediated through classical cancer-related pathways and immune cell infiltration. Additionally, we propose that the aforementioned three small molecule hold promise as potential therapeutics for modulating palmitoylation, thereby offering novel avenues for cancer therapy.
000285439 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000285439 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000285439 650_7 $$2Other$$aCancer
000285439 650_7 $$2Other$$aDNA methylation
000285439 650_7 $$2Other$$aImmunotherapy
000285439 650_7 $$2Other$$aPalmitoylation
000285439 650_7 $$2Other$$aSmall molecular
000285439 650_7 $$2Other$$ac-Myc
000285439 7001_ $$aLiu, Yugeng$$b1
000285439 7001_ $$0P:(DE-He78)a92f91afa83da73641a4f3abec1d3c6d$$aLi, Xianzhe$$b2$$eFirst author$$udkfz
000285439 7001_ $$aRao, Menglan$$b3
000285439 7001_ $$aLi, Dawei$$b4
000285439 7001_ $$aRuan, Xiaolan$$b5
000285439 7001_ $$aLi, Shanglin$$b6
000285439 7001_ $$aJiang, Zhenyou$$b7
000285439 7001_ $$00000-0003-3045-4444$$aZhang, Qiang$$b8
000285439 773__ $$0PERI:(DE-600)2118570-0$$a10.1186/s12967-023-04611-8$$gVol. 21, no. 1, p. 826$$n1$$p826$$tJournal of translational medicine$$v21$$x1479-5876$$y2023
000285439 909CO $$ooai:inrepo02.dkfz.de:285439$$pVDB
000285439 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a92f91afa83da73641a4f3abec1d3c6d$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000285439 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000285439 9141_ $$y2023
000285439 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ TRANSL MED : 2022$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:07:28Z
000285439 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:07:28Z
000285439 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T15:07:28Z
000285439 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ TRANSL MED : 2022$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-20
000285439 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-20
000285439 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000285439 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000285439 980__ $$ajournal
000285439 980__ $$aVDB
000285439 980__ $$aI:(DE-He78)C070-20160331
000285439 980__ $$aUNRESTRICTED